Differential expression of TOB/BTG family members in patients with plaque psoriasis: cross-sectional study.

Autor: Barrera-Ochoa, Carlos A., Fonseca-Camarillo, Gabriela, Vega-Memije, María Elisa, Furuzawa-Carballeda, Janette, Uriarte-Ruiz, Karen, Fernández-Camargo, Dheni Aidé, Yamamoto-Furusho, Jesús K.
Zdroj: Immunologic Research; Apr2024, Vol. 72 Issue 2, p234-241, 8p
Abstrakt: TOB/BTG is a family of antiproliferative proteins that play an important role in the regulation of immune responses, acting as lymphocyte activators and macrophage-mediated cytotoxicity. No previous studies have explored their role in patients with psoriasis. The aim of this study was to characterize the expression of TOB/BTG family and their co-localization in skin from patients with psoriasis. This is an exploratory, observational, and cross-sectional study that included 24 plaque psoriasis patients and 15 controls. Gene expression of TOB/BTG family was determinate by RT-PCR. Protein products of TOB/BTG were evaluated by immunohistochemistry and compared with control skin tissues. Holm-Sidak's multiple comparisons test was performed. TOB/BTG family mRNA levels and protein expression were significantly decreased in psoriatic skin tissue compared to non-inflammatory control skin tissue. Double-positive cell TOB1/2, BTG1,2 and BTG4/CD16 expressions were found in normal control skin tissues through epidermis and dermis (p < 0.001) and lesser percentage in patients with mild, almost absent in moderate-severe plaque psoriasis. This is the first report of the TOB/BTG family gene and protein expression in skin tissues by a CD16 + subpopulation in plaque psoriasis. TOB/BTG family protein might represent a new therapeutic target among immune-mediated inflammatory diseases. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: